Imaging Endpoints is contributing to a new Nature publication showing that Quantitative MRI of vascular disrupting agents may aid cancer drug development.
To read the full study, visit https://www.nature.com/articles/s41598-020-71246-w.
Imaging Endpoints was founded to Connect Imaging to the Cure™
Imaging Endpoints was founded to Connect Imaging to the Cure™ and is making its vision a reality with a record year for supporting numerous regulatory approvals of new, life-saving oncology drugs for adults and children. To read more about how our… Read More
Imaging Endpoints is involved in extensive and cutting-edge COVID-19 imaging
We are offering the detection and standardized recording of the clinical and radiological disease features of COVID-19 infection, Radiomic Analysis, CD8+ Analysis and AI Analysis of SARS-CoV-2 for clinical trials. For more information, see https://imagingendpoints.com/covid-19/covid-analysis/
Big iData: Imaging Endpoints is uniquely positioned to house millions of images across multiple disease types in searchable databases that enable deep imaging research and development.
Our novel technology enables us to structure, de-identify and search radiology reports and their associated images in order to select datasets for specific, targeted research projects. Longitudinal patient data combined with our AI analysis provides opportunity for development of early… Read More
Imaging Endpoints is very thankful to be experiencing growth and hiring during this challenging time.
We are seeking exceptional talent for dynamic positions in numerous areas of our Company. Imaging Endpoints is a team of diverse and driven professionals with a goal to change the world by Connecting Imaging to the Cure. Learn more about… Read More
Imaging Endpoints announced today that it has supported another U.S. Food and Drug Administration (FDA) approval for a new, life-saving therapy
Imaging Endpoints announced today that it has supported another U.S. Food and Drug Administration (FDA) approval for a new, life-saving therapy. The New Drug Application (NDA) was granted accelerated approval, for the Company’s pharmaceutical client, and is indicated for relapsed… Read More
World’s Leading Scientist and Physicians
Imaging Endpoints is a leader in science and technology, providing comprehensive imaging services and technology solutions throughout the clinical trial process. Our 100-plus radiologists and physician specialists take a cutting-edge approach to clinical trials at every stage. Learn more about… Read More
Imaging Endpoints has experienced more than a decade of high-growth
Imaging Endpoints has experienced more than a decade of high growth and is perhaps the fastest-growing imaging CRO globally. That is a testament to our amazing staff and their dedication to Connect Imaging to the Cure. Learn more about opportunities… Read More
Imaging COVID-19
Imaging Endpoints is involved in cutting-edge COVID-19 imaging and offers the detection and standardized recording of the clinical and radiological disease features of COVID-19 infection, Radiomic Analysis, CD8+ Analysis and AI Analysis of SARS-CoV-2 for clinical trials. For more information,… Read More
On Point Webinar Series
Did you miss the inaugural On Point webinar discussing how the use of radiology and advanced technologies can be used to measure response for COVID-19 treatments and vaccines and lead to better decisions? Visit https://imagingendpoints.com/on-point/ for an on-demand version of… Read More
